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Abstract 
This paper presents a detailed account of policy-making in a contemporary risk 
communication arena, where strong power dynamics are at play that have hitherto 
lacked theoretical analysis and empirical validation. Specifically, it expands on the 
understanding of how public health policy decisions are made when there is a weak 
evidential base and where multiple interpretations, power dynamics and values are 
brought to bear on issues of risk and uncertainty. The aim of the paper is to 
understand the role that power and expertise play in shaping public health risk 
communication within policy-related debates. By drawing on insight from a range of 
literatures, the paper argues that there several interacting factors that shape how a 
particular narrative gains prominence within a wider set of perspectives and how the 
arguments and findings associated with that perspective become amplified within the 
context of policy choices. These findings are conceptualised into a new model - a 
policy evaluation risk communication (PERC) framework - and are then tested using 
the Electronic cigarette debate as a case study. 
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Introduction 
Risk communication processes are critical in shaping public understanding of health-
related risks (Bennett, 2010; Fischbacher-Smith, Irwin, & Fischbacher-Smith, 2010; 
Veland & Aven, 2013) and have become central to public health approaches in many 
countries, including United Kingdom (UK) (Alaszewski, 2005; de Jong, Ros, & 
Schrijvers, 2014; Plough et al., 2013). Risk communication is the exchange of risk 
information (resulting from both human and natural processes (Löfstedt, 2008; 
Veland & Aven, 2013)) between various stakeholder groups, such as government 
agencies, professional organizations, scientists, corporations and individual citizens 
(Covello, Slovic, & von Winterfeldt, 1986). Risk communication contributes 
significantly to shaping the public understanding of risk and influences the 
formulation of policy perspectives around managing risk (Fischbacher-Smith, 2012; 
Irwin, 2014; Smith, 1988; Stilgoe, 2007; Stilgoe, Irwin, & Jones, 2006; Welsh & 
Wynne, 2013).  
 
To be effective, risk communication needs to be framed so that the encoding of the 
message allows for its effective decoding by its recipients (Bernstein, 1964; Fortune 
& Peters, 1995). Any failure to ensure that this process takes place, can lead to 
distortion in the message and a misunderstanding of the nature of the risk and any 
associated uncertainty in the risk assessment process. Within this context, powerful 
interest groups have sought to use their knowledge and expert resources in a bid to 
protect their interests in public health policy-making by shaping the discourse around 
risk (Demeritt & Nobert, 2014; Hardy & Maguire, 2016; McKell & De Barro, 2016; 
Smith, 1988; Smith, 1990; Veland & Aven, 2013; Warner & Kinslow, 2013).  
 
This paper examines the processes of risk communication within the context of the 
electronic cigarette (vaping) debate within the UK. In particular, it considers how 
power and expertise shape public debates that involve a high degree of uncertainty 
and a requirement for an unambiguous burden of proof. Particular consideration is 
given to how policy decisions are made, especially where there is a weak evidential 
base and where multiple interpretations, power dynamics and values are brought to 
bear on public health risk issues. The core of the paper examines how risk debates 
develop, such that a particular perspective becomes dominant in shaping policy. 
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More specifically, it explores how a risk argument evolves through the key stages of 
scientific verification and then policy formulation.  A theoretical framework is 
proposed that recognises the role of power in that process - the PERC (Policy 
Evaluation Risk Communication) framework – and is applied to the case of E-
Cigarettes.  
 
This paper draws on archival and documentary evidence relating to E-cigarettes as a 
means of developing and applying the PERC framework.  The records allow 
examination of a chronology of the debate and insight into how communications 
took place and between whom; i.e. there is a breadth of coverage of events and 
contexts over time (Yin, 2011, 2013). Documentary data sources also help establish 
the validity of interpretations (Briggs, Morrison, & Coleman, 2012) within the 
cultural context in which they were generated (Briggs et al., 2012). Sources used 
include press releases, articles and media statements, official documents from 
government departments and organisations, reports from non-profit organisations, 
and scientific committee reports. 
 
In analysing the data, close attention was paid to the description and scope of 
published sources used, sampling frames, and summaries of data collection 
procedures. Document analysis was undertaken in light of established social science 
methods (Bowen, 2009) where the study of evolving events develops a sound 
understanding of a case study (Elo & Kyngäs, 2008). Evidence provided in this study 
is presented chronologically (Baxter & Jack, 2008; Sandelowski, 2000) allowing 
debates to be understood as they occur.  
 
Perspectives on Risk Communication 
 
The literature on risk communication can be characterised by three overlapping 
perspectives: science and technology studies (STS), communication studies, and 
management (including risk and crisis management) (Irwin, 2014; Jasanoff, 2015; 
Renn, 2015; Stilgoe, 2016). These three perspectives correspond to Wardman 
(2008), “normative,” “instrumental,” and “substantive” imperatives that touch upon 
‘values’, ‘power’ and ‘co-production’ respectively in risk communication. This study 
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draws upon these three disciplinary perspectives, although it is more inclined 
towards the management perspective, and subscribes to the view that risk 
communication is a field of play and competition (Bourdieu, 1998) between 
competing stakeholders’ interests (Petts et al., 2001; Pidgeon & Barnett, 2013). 
Stakeholders include: government agencies, professional organizations, scientists, 
corporations, non-governmental organisations and individual citizens (Covello et al., 
1986; Irwin, 1995). Each stakeholder seeks to frame the agenda in a way that serves 
their own interest and drives the communication dynamics of their own discourse 
(Murdock et al., 2003; Pidgeon & Barnett, 2013). Framing processes typically define 
the parameters of the risk problem, especially when establishing the nature and 
source of the hazard, and this can, in turn, shape any proposed policy solutions 
(Entman, 2014; Fischbacher-Smith et al., 2010). Invariably, this can influence the 
parameters of risk communication and contextualise it as an essentially technocratic 
process that is reliant on expert judgement.  
 
Unfortunately, this means that risk communication is often prone to abuse by 
powerful interest groups, especially where there is considerable uncertainty around 
the nature of the hazard and its probabilities of occurrence  and where vested 
interests combine with unequal status between stakeholder groups to undermine 
public opposition to risk-based activities (Collingridge & Reeve, 1986b; Smith, 
1990). Such inequalities can create significant differences in the representations of 
the risks (Taghavifard, Damghani, & Moghaddam, 2009), especially in new and 
emergent forms of activity where there is little or no prior scientific understanding of 
the nature of the hazards.  
 
Understanding risk is, therefore, a potentially double-edged process. Whilst the 
potential for harm in activities is often the dominant perspective of policy-makers, 
inadequacies or errors in understanding and the framing of the nature of the risk can 
cause delays in developing appropriate policy interventions (Bero, 2003). In 
healthcare, these delays could potentially be lifesaving or life enhancing whilst errors 
in framing risk may result in policy interventions that do not reflect the available 
evidence, resulting in either over-regulation that could be costly and over-
precautionary, or under-regulation with resultant prolonged public exposure to health 
risks and danger (Diggle, 2010; Fischbacher-Smith, 2010). The negative 
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consequences can be heightened where there is considerable scientific uncertainty 
about the nature of the risk and its emerging properties, with associated impacts upon  
sense making and the risk assessment process (Bennett, Calman, Curtis, & 
Fischbacher-Smith, 2010; Renn, 2008). Typically, it is the less powerful groups 
among larger sections of society who will bear the consequences of any errors in 
policy decisions.   
 
The Evolving Risk Debate – Public Concerns, Expert Speculation and 
Media Attention 
Concerns around public health, coupled with anecdotes and negative tales of 
personal experiences, often attract media attention (Bromley & Segerson, 2012) 
and can create a wider awareness of the issues (Shih, Wijaya, & Brossard, 2008).  
Anecdotes, such as a doctor reporting an observation of an increase in incidences of 
lung cancer amongst smokers (Kasperson et al., 1988), can significantly shape 
public perceptions around the management of risk  and may impact on policy, even 
if only by providing hypotheses for scientific research (Moore and Stilgoe, 2009). 
Issue attention occurs where a potential hazard suddenly becomes a focal point of 
media and public debate for a period of time, thereby creating political pressure for 
risk assessment (Downs, 1996). Gaps in the knowledge base or insufficient 
information are often addressed by seeking out potential sources of expertise for 
comment and insight (Kandlikar, Ramachandran, Maynard, Murdock, & Toscano, 
2007). Technically-based judgements of risk are often deemed more credible than 
lay perspectives, because of the legitimacy associated with their expert knowledge 
domain. However, when experts move outside of that knowledge domain, their 
ability to make such ‘expert’ judgements is eroded. Thus, although many debates 
around risk are seen to be technical in their scope, there has been criticism of this 
technocratic view by those who see many of the interpretations about risk as social 
constructions rather than purely objective assessments (see, for example, Beck, 
1986, 1992; Giddens, 1990; Nelkin, 1989; Stallings, 1990).  
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Technical Debate 
The technical verification of a public health risk is essential for rationalising policy 
decisions and risk mitigating strategies that are already in place (Fischer, 1990, 
1998). Technical verification uses a scientific and evidence-based methodology in 
determining areas of known fact and determining their significance to public health 
and safety. Evidence from this process then shapes policy but it can often fail to 
deal with issues of emergence adequately and communicate uncertainty effectively. 
Emergence may, therefore, continually shift the requirement for a clear burden of 
proof amongst competing stakeholders. Problems may also arise from disciplinary 
differences because of epistemological and methodological differences with regard 
to facts, rigor, causal explanations and research goals (Collingridge & Reeve, 
1986b). These differing paradigmatic perspectives may lead to different 
conclusions, thereby creating ambiguity and conflict in the identification of risk 
and associated policy debates (Collingridge & Reeve, 1986a; Collingridge & 
Reeve, 1986b; Fischer, 1990). Collingridge and Reeve (1986a; 1986b) suggest that 
technical inputs into policy debates can either heighten conflict or create a sense of 
agreement about the issues. Scientific inputs can be seen to contribute to either an 
under-critical debate, where there is no effective dialogue due to the role played by 
powerful interests in supressing opposing views; or an over-critical debate, where 
there is perpetual conflict around the issues.  (Collingridge & Reeve, 1986b). The 
effect of science within the policy-making process is thus determined by who has 
the power to influence the discourse.  
The technical verification process may, in turn, also influence debates around risk 
tolerability and acceptability. The core argument here is that risk assessment is not 
simply a matter of an objective analysis of evidence, but rather the  creation of 
contexts within which statements and operations sound ‘scientific’ and valid 
(Latour, 1987). The interaction and communication between certain stakeholders 
groups allow privileged access to exclusive information and policy-makers, 
enabling them to discuss and express certain political opinions that can have 
powerful influences on policy-choices (Sutton, 1999). Policy framing of public 
health risk is essential as it is often followed by risk reduction actions (Korn, 
 7 
Gibbins, & Azmier, 2003) designed to bring about the desired behavioural 
responses.  
Figure 1 depicts the different stages of an evolving risk debate from initial anecdote 
to policy formulation. While Figure 1 shows a linear flow from public concern to 
policy debate, in reality, risk debates may begin at any stage and iterate, similarly 
public health risk arguments may emerge at all stages at the same time. Figure 1 
highlights the relationships between the technical evaluation of risk and policy 
debate and policy formation.  
 Figure 1: The different stages of risk debates 
  
The Policy Evaluation Risk Communication (PERC) Framework  
The Policy Evaluation Risk Communication (PERC) framework (see Figure 2) 
illustrates the factors that influence how policy-makers evaluate risk and 
uncertainty, especially where there are multiple perspectives, strong power 
dynamics and values at play. The PERC framework assumes that the processes 
around the “social amplification of risk” (Kasperson et al., 1988; Renn, Burns, 
Kasperson, Kasperson, & Slovic, 1992) drives the transition of risk debates 
between the over critical and under critical models. The PERC framework 
identifies power, expertise, communication and trust as key factors shaping the 
amplification (or attenuation) of risk perspectives within the policy context. The 
framework also shows that the evolving nature of information, evidence and 
knowledge shapes how power, expertise, communication and trust are brought to 
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bear on risk communication, and in turn further shape a risk argument. The central 
drivers of this process need to be considered in turn.  
Figure 2: Policy Evaluation Risk Communication (PERC) framework  
 
  
Power: Policy arguments relating to risk are embedded within institutional, 
productive, structural and resistive forms of power, which means that power is fluid 
and creates imbalances in ways that enhance or inhibit certain stakeholder groups’ 
influence on risk communication. Power may be exercised by shaping the policy 
agenda (Bachrach & Baratz, 1962), controlling risk information and expertise 
(Lukes, 2005), establishing stakeholder relationships (Barnett & Duvall, 2005) and 
resisting dominant worldviews (Foucault, 1980). 
By shaping the risk agenda and prioritising objectives, policy-makers and 
regulators are able to shape the direction of the risk debate and the issues that are 
deliberated upon. The ability to control risk information, validate appropriate 
expertise and decide what, when or how much information or expertise is made 
available or concealed, may also drive the amplification (or attenuation) of certain 
policy arguments relating to risk. In addition, there is the power that comes with a 
stakeholder relationship that allows an exchange of views and political opinions 
and which may generate a dominant hegemony within certain risk discourses. In 
addition, risk communication practices (Power, 2007) that view science as superior 
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to other forms of knowledge and expertise and which shape how risk is accessed, 
interpreted and communicated are further avenues for social amplification (or 
attenuation) of public health risk.  
Expertise:  Another driver of the amplification (or attenuation) of risk within the 
policy domain concerns the ways that experts interpret evidence, the determination 
of what constitutes evidence, and which forms of expertise are legitimised 
(Collingridge & Reeve, 1986b; Irwin, 1995). Research suggests that technical, 
rather than experiential expertise has more credibility and so technical expertise is 
often privileged within the policy context. However, several problems with the use 
of technical expertise have been identified as influencing how evidence is 
interpreted and how this frames risk signals. These include: the domain specificity 
of expertise, the interdisciplinary nature of public health risk, the “paradigm 
blindness” (Fischbacher-Smith, 2012) that often influences how experts 
acknowledge challenges to their worldview, and the fact that technical expertise is 
socially constructed through established training and validation structures that can 
reinforce powerful and vested interests. It is therefore important that other forms of 
expertise are considered especially the experience of those who are in close 
proximity to the risk, in order to improve on the robustness of evidence (Stilgoe, 
2007) and to ease the burden of proof (Fischbacher‐Smith & Fischbacher‐Smith, 
2009). 
Communication: The processes around the communication of risk between various 
stakeholder groups is another factor that shapes risk amplification (Smith & Irwin, 
1984; Smith & McCloskey, 1998). Using language relevant to all stakeholders 
involved in risk communication is essential in terms of translating the language of 
an expert in a way that is usable by decision or policy-makers, while highlighting 
uncertainties where they exist (Adekola, Fischbacher-Smith, Fischbacher-Smith, & 
Adekola, 2017; Bernstein, 1964; Smith, 1990; Smith & McCloskey, 1998). The use 
of language where the receptor cannot decode the meaning reduces or amplifies the 
significance and use of any expert proposition and may lead to an impasse in 
conflict resolution, a problem that is exacerbated by social media.  
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Also important is the quality of the feedback provided so that sensitive issues are 
addressed and dealt with appropriately: one-way risk communication may heighten 
tensions around risk acceptability, as it does not allow for clarification of meaning 
or discussion of sensitive issues. Furthermore, where there is considerable 
uncertainty in the issues then stakeholders have more scope to refute or undermine 
damaging arguments, speculations may increase, and the operating theories brought 
to bear on debates may push arguments towards an over-critical model.  
Trust and credibility: Evidence from the literature has highlighted the importance 
of trust or perceived credibility of the source of risk information (Mayer et al., 
1995). The credibility of the source contributes to whether messages resonate with 
the audience (Frewer et al., 2003). Distrust contributes to heightened resistance in 
risk arguments that often leads to a distortion of the risk message. However, under 
circumstances where there is trust, the receiver of risk information may even 
become a walking and talking advertisement actively sharing the views of the other 
actors among his social network that may bring about hegemony of risk discourse 
in the policy domain. 
Information, evidence and knowledge: What is also important is how power, 
expertise, communication and trust are contingent upon the evolving nature of 
information, evidence and knowledge and how that can potentially shift risk 
arguments forward and backward between under critical and over-critical models  
(Fischbacher-Smith, 2012; Smith, 1990). As information, evidence and knowledge 
become available, it is possible that the uncertainty present in the discussions may 
decrease. This may result in a shift in the balance of power between the different 
stakeholders, alter how power and expertise are effected and in turn, influence the 
nature of communication and trust and how the public perceived risk 
communication.  
Behavioural response to institutionalised policy perspective:  Policies that are 
designed to mitigate public health risk often prompt behavioural responses to 
perspectives about the nature of those risks. Significant response mechanisms are: 
the nature of social trust in policy-makers and public health institutions (Renn & 
Levine, 1991), the ability of individuals or groups to resist a legitimised risk 
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perspective, signal value (Kasperson, 2012), and the distribution of costs and 
benefits that can steer emotional responses to institutionalised policy perspectives 
(Adekola et al., 2017). Undesired behavioural responses or emergent problems may 
compel the government to change its policy and risk mitigating strategy. This is 
akin to Foucault’s resistive power (Foucault, 1982) but may not accompany change 
to deep core policy ideologies or beliefs (Sabatier & Jenkins‐Smith, 1993) in 
relation to the risk.  
Behavioural responses may also create unintended problems due to the emergent 
properties of risk, in turn giving rise to new areas of uncertainty, new research 
questions and challenges to existing policies. New research questions and new 
evidence following a technical verification may move risk arguments towards the 
over critical model and restarting the entire debate. The assumption made by the 
PERC framework is that policy debates relating to risk arise from, and are 
conducted within, a public space in which there are multiple interactions between 
power and expertise that enhance or inhibit risk communication. These interactions 
can also create or destroy trust and credibility, and privilege certain social and 
professional relationships over others. As such, a degree of bias can arise from the 
asymmetries of power underpinning these interactions and processes that in turn, 
perpetuate the domination of certain risk perspectives and/or shape the 
prioritisation of issues and debates in the policy domain. 
The emergence of Vaping as an alternative to cigarettes 
The current debate around the safety of e-cigarettes (popularly known as vaping) 
emerged following the introduction of electronic cigarettes (EC) into the European 
market in 2006 in what was initially seen as a safer alternative to conventional 
cigarettes. However, in 2008, the World Health Organisation (WHO) raised concerns 
about the promotion of these “safer alternatives” because of the then under-
developed scientific understanding of their safety and efficacy (WHO, 2008).  In 
July 2009,  they raised further concerns that ECs were being targeted at young 
people and that EC packages lacked appropriate health warnings (CASSA, 2014).  
Thereafter, a series of industry-commissioned and other studies took place, each 
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presenting differing accounts of the risks, thereby generating a contested 
environment around issues of product safety.   
 
These reviews were diverse and provided different accounts of the issues. A report 
commissioned by EC manufacturer Ruyan, for example, reported ECs to be a safer 
alternative to conventional cigarettes with only trace toxins found to be contained 
within them (Laugesen, 2008). The report claimed that ECs containing nicotine 
reduced the desire to smoke, were more pleasant to use than the nicotine inhalators, 
and performed significantly better than a placebo EC (Bullen et al., 2010). Flouris 
and Oikonomou (2010) reviewed reports published by the US Food and Drugs 
Administration (FDA), Health New Zealand (HNZ), a private enterprise, and 
Demokritos, a publicly funded Greek research institute. The reports revealed similar 
findings in that they identified different harmful constituents of EC liquid content, 
but they differed in their interpretations of the implications. The US FDA focused on 
the potential harm of the liquid contents to human health, whilst the HNZ focused on 
the relative risks of tobacco and ECs. In contrast, the Demokritos report focused 
mainly on the consumer experience, whilst maintaining a neutral position of the 
safety or efficacy of ECs.  
 
Unsurprisingly, given the growth of the EC market, and the nature of the emerging 
scientific evidence, reports and reviews of this nature were produced at an increasing 
rate and reflected the various ways in which the debate could be considered. 
Eissenberg (2010) reported, for example, that ECs were less effective in suppressing 
cravings than conventional cigarettes, raising further questions about whether ECs 
were the efficient replacement manufacturers claimed.  Bullen et al (2010) addressed 
the short term effect of an EC delivery on desire to smoke and on withdrawal, and 
suggested that ECs could be used as an aid to stopping smoking and had potential for 
long term use (Bullen et al., 2010). In 2011, the British Cabinet Office’s Behavioural 
Insights Team (BIT, also known as the ‘Nudge Unit’) endorsed tobacco harm 
reduction by changing smoking habits.  Within this context, ECs have been cited as 
potentially effective substitutes for tobacco that could save tens of thousands of lives 
(Stratton, 2011).  
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In 2012 there were position statements made from consumer groups such as the 
Consumer Associate or Smoke Free Alternative Association (CASAA), Electronic 
Cigarette Consumer Association UK (ECCA UK), Stelda NL (Netherlands), and 
other European companies who also organized the first World Vaping Day, calling 
for their right to vape (CASSA, 2014). At the same time, questions were raised about 
the significance of passive vaping in the debate. Schripp, Markewitz, Uhde, and 
Salthammer (2013), for example, found that ECs do not produce second-hand smoke 
as conventional cigarettes do. Instead, bystanders are exposed to a mist of exhaled 
vapour, which undergoes changes in the human lungs similar to decomposition and 
evaporation (Schripp et al., 2013). This view positioned the rights of vapers and the 
rights of non-vaping bystanders directly in conflict.  By the end of 2012, several 
studies concluded that ECs are safer when compared to tobacco smoking, and are an 
effective smoking cessation aid (see, for example, Bullen et al., 2010; Etter & 
Bullen, 2011; Flouris et al., 2012). Other studies raised caution, pointing to passive 
vaping, inconsistency with labelling, and questioning the long term benefit of 
vaping, see for example, (Eissenberg, 2010; Schripp et al., 2013).   
 
Between 2013 and 2016, emphasis on EC regulation grew, and tensions heightened 
as the tobacco industry became involved in the debates. Fierce scrutiny of evidence 
and arguments between stakeholder groups served to increase the degree of 
difference between stakeholders’ points of view just as, in January of 2013, the first 
television advert for ECs on a national, mainstream British channel was launched by 
E-Lites (Sweney, 2013).  In March 2013, the outcome of a public consultation to 
bring nicotine-containing products (NCPs), including ECs within the medicines 
licensing regime was published by the Medicines and Healthcare Products 
Regulatory Agency (MHRA). Medical and public health communities strongly 
supported regulating ECs under the medicines regulatory framework (MHRA, 2013). 
Those against the MHRA medical framework regulation were mainly importers and 
users of unlicensed electronic cigarettes who feared it could lead to a ban on 
available products, which would force EC users back into smoking tobacco (MHRA, 
2013). 
 
The Commission on Human Medicines (CHM), which advises the UK government, 
then established an expert working group (MHRA, 2013) and three months later it 
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announced that the UK Government had decided that it would regulate all NCPs, 
including ECs, as medicines to ensure the safety of the product and to address the 
issue of distrust about the quality of some EC devices and their content. Thus, 
although some proponents of ECs considered them beneficial to public health, the 
policy stance adopted was that ECs were at that point, an inadequate intervention.  
The decision to regulate ECs in the same way as medical devices was taken to ensure 
that high quality products were made widely available and that smokers had an 
effective alternative. Regulation and marketing of ECs thus changed in ethos and 
focus from a consumer product, which was not subject to test before being put on 
sale to the public, to one which is regulated under the medicines regulatory 
framework, requiring manufacturers to apply for a medicinal licence from the 
Medicines and Healthcare products Regulatory Agency (MHRA).  
 
Later in 2013, British American Tobacco (BAT) and China National Tobacco 
Corporation jointly invested in a subsidiary (CTBAT International Limited) to 
launch their first EC product, Vype, in the UK (BAT, 2014).  In February of 2014, 
the European Parliament approved a revised European Union Tobacco Product 
Directive. This regulates ECs with more than 20 mg/Ml nicotine concentrations; a 
quantity equal to that in a pack of cigarettes (Gallagher, 2014) or with intended 
therapeutic use, following which they fell under the medical devices directives. The 
directive stipulated that ECs had to be childproof, packaging should have 
information relating to liquid composition, effects, with health warnings (EC, 2014). 
 
Unsurprisingly, this was met with divergent views on the extent to which young 
people would be deterred from smoking (Gallagher, 2014), a divergence further 
fuelled by subsequent revisions to the Directive. Because of subsequent directives, 
advertising was prohibited for nicotine containing devices not licensed as medicines, 
health warnings are to be placed on all products and, data on nicotine uptake are to 
be provided subject to restrictions on total nicotine content. When used under normal 
conditions, suppliers are to take total responsibility for quality and safety (EC, 2014).  
Any EC that was not regulated by MHRA would be governed under the European 
Union Tobacco Products Directive (TPD) (EC, 2014). 
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The on-going divide within the scientific and public health communities was clearly 
illustrated when, in 2014, 53 nicotine science specialists and public health policy 
experts wrote to Dr. Margaret Chan, of the World Health Organization (WHO). In 
the letter, they argue that regulating ECs similar to tobacco products would reduce 
the numbers of people relying on ECs to stop smoking and this, could potentially 
cost lives (Dreaper, 2014). They viewed ECs a significant step in health innovations 
made in the 21st century that could potentially save millions of lives. They asked 
WHO to resist the urge to control and suppress EC (Dreaper, 2014; 
Nicotinepolicy.net, 2014).  In response, 129 public health and medical experts from 
31 countries of WHO region, signed a letter to Margaret Chan. This group of 
experts, in contrast, called for new controls on EC and urged the WHO to be mindful 
of tobacco industry tactics in shaping arguments around EC regulation (Aktan et al., 
2014). 
 
Similar divisions and disagreement were also played out in the UK. The British 
Cabinet Office were optimistic about the potential benefits of ECs as an effective aid 
to smoking cessation and offering a safer alternative to those who do not want to quit 
smoking. Whilst the Behavioural Insights Team endorsed had ECs in 2011 as 
potentially effective substitutes to tobacco (Stratton, 2011), other public institutions 
such as the British Medical Association (BMA), the UK Faculty of Public Health, 
and the European Commission took a more precautionary stance and called for strict 
control and regulation of EC devices. They also expressed concern that ECs may be 
a potential gateway to re-normalizing smoking (Rigotti, 2015) and might be 
exploited by the tobacco industry (Kremer, 2013). For example, the BMA raised 
concerns that ECs may re-normalise smoking, such that could undermine the 
smoking bans that helped de-glamorise tobacco in United Kingdom (Kremer, 2013). 
Other areas of contention included: inadequate safety controls to prevent accidental 
injury, monitoring of trends in dual use of EC in combination with continued 
tobacco smoking, regulation of marketing activity, and the involvement of the 
tobacco industry in the EC market.  
 
The EC Debate through a PERC Lens  
The central actors involved in the initial phase of the debate were:   
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 the WHO, which raised the concern on the lack of evidence around the safety 
and efficacy of ECs;  
 the scientific community who were called upon to conduct more research in 
this arena; and  
 the various EC companies and retailers who claimed that ECs are a safe 
alternative to tobacco and who benefited commercially.  
 
The EC debate has occurred in a socio-political context where information and 
communication technologies (ICT) allow interactive and instant debate via social 
media and where, in contrast to tobacco debates in the 1950s, there is more emphasis 
on citizens’ participation and deliberative policy-making. The unfolding of events 
suggested a sharp divide within the scientific and public health communities in their 
interpretation of available evidence that mirrored a divide in the wider society. This 
illustrates Collingridge and Reeve’s (1986) over-critical model, where the science 
becomes contested and where multiple interpretations exist around the available 
evidence and the expertise used to evaluate it. The core argument concerned the need 
to get the regulatory framework right for a device that could potentially save 
thousands of lives (Stratton, 2011); the need for more research to be done before any 
conclusions can be drawn (Smith, 2012); and the need to retain familiar habits and 
nicotine intake, to encourage cessation (CASSA, 2012). This period was marked at 
the end of 2012 by the entry of big tobacco companies into the electronic cigarette 
market creating tension and heightened scrutiny in the risk acceptability debate 
thereon. 
 
With reference to the PERC framework, the evolving events suggest that the 
institutional power of the WHO was significant in pointing out that the lack of 
knowledge about the safety and efficacy of ECs was important within the context of 
their declared public health benefit. The WHO’s call for research into the safety and 
efficacy of ECs seems to have driven scientific research around safety and efficacy. 
The MHRA-led public consultation on how to regulate ECs also influenced the 
direction of the vaping debate. This shifted the decision-making power from the 
policy to the public domain, although this may have been a reflection of a more 
general shift towards democratic policy-making in contemporary political life. In 
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terms of expertise, the public relied on technical expertise to make sense of the 
benefits or risks of electronic cigarettes. This suggests that while the public were 
involved in decision-making relating to regulation; public engagement in the 
development of accepted knowledge around the safety and efficacy of ECs was 
limited to the acceptability debate with scientists playing leading role in the technical 
debate. The vaping debate also highlights how the presence or absence of trust could 
influence the nature of tension, and scrutiny of the debate around risk acceptability. 
For example, the entry of powerful tobacco companies in the EC industry fuelled 
tension and suspicion, and further heightened scrutiny of evidence and arguments 
brought by stakeholders in the vaping risk debate. 
 
In the second examined phase of the vaping debate (the period between 2013 and 
2016), the entry of tobacco companies in the EC market saw more heightened 
tension and scrutiny of scientific evidence and interpretation. This created greater 
visibility for divisions and disagreements between the various stakeholders groups. 
Some of the situational factors that may have contributed to this scientific division 
and disagreement are: (a) the absence of economically resourced stakeholder groups 
before late 2012, (b) caution towards the use of delay tactics by EC companies in the 
same way as was seen in the tobacco debate, and (c) the fact that political power was 
less obvious earlier on in the technical debate relating to vaping. The results of the 
MHRA-led consultation were also published in this period. Medical and public 
health communities strongly supported the application of the medicines regulatory 
framework on ECs (MHRA, 2013). However, there were concerns on the part of 
marketers and users of unlicensed ECs that inappropriate regulation could lead to a 
ban on available products. Three months after the publication of the public 
consultation, the UK Government announced that all NCPs, including ECs, would be 
regulated as medicines and thereafter, the EU directive was adopted.  
 
With reference to the PERC framework, structural power can be seen to be 
expressed for instance in the stakeholder relation between expert committees and 
policy-makers. For example, in 2015, shortly after the public health England’s expert 
conclusion that ECs are around 95% less harmful than smoking (McNeill et al., 
2015), the UK government made the decision that EC could be prescribed by NHS 
doctors to help smokers who wanted to quit smoking (Tonkin, 2015). Such a 
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stakeholder relationship privileges this kind of technical expertise over other forms 
of expertise (e.g. experiential expertise) in the policy perspective taken to risk as it 
provides a platform for interaction and exchange of views with policy-makers. 
Stakeholder relationships create power imbalances altering the degree of influence 
that stakeholder groups are able to bring to bear on public health risk 
communication.  
 
What was also important were how technical experts’ interpretations and frames of 
argument shaped the discourse around vaping risk. There were scientists and public 
health expert groups who viewed ECs as an effective aid to smoking cessation, and a 
safer alternative to those who do not want to quit smoking. On the other hand, there 
were those who called for a precautionary stance and for stricter control and 
regulation of EC devices. The latter group of experts expressed concern that ECs 
may be a potential gateway to renormalizing smoking, undermining several years of 
effort in deglamourizing smoking, and that ECs may be exploited by the tobacco 
industry to recruit non-smokers and children who may then go on to smoke 
cigarettes. The nature of interpretation is dependent on how the relative risks are 
judged, from the perspective of either the smokers or non-smokers. 
 
In terms of communication, one unique feature of this debate was how MHRA-led 
public consultation allowed a two-way communication between policy-makers and 
the public, and how that has allowed different group of stakeholders to exchange 
views and opinions with policy-makers. This may have eased public acceptability of 
EC regulation under the medical regime, as the public felt trusted and included in the 
decision as seen in the report of the consultation that shows a strong public support 
for medical consultation of ECs. The vaping debate also highlights the importance of 
(mis)trust in public health risk communication, around how the presence or absence 
of trust could influence the nature of tensions in, and scrutiny of the debate around 
risk acceptability. An important issue within this latter stage of the debate was how 
entrenched mistrust inherited from the smoking debate shaped the vaping debate. 
This was evidenced in the signed letter to Margaret Chan, of World Health 
Organisation – referred to earlier - that called for new regulation and control of ECs 
and expressed scepticism about the involvement of industry in public debate.  
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Conclusions 
Two questions that might be asked of this study are: 
 what will it take to ensure that public health risk communication is not 
dominated by a few influential people or groups at the expense of other 
legitimate views?; and 
 where a few influential people/groups do dominate, how can we ensure that 
they do not gain at the expense of the wider public health?  
These questions are pertinent where there is considerable uncertainty around the 
nature of the risk and where vested interests combine with unequal status between 
stakeholder groups; arguably a common scenario when public health is concerned 
(Fischbacher-Smith & Hudson, 2010; Hudson, 2009). 
 
Firstly, there is the need to ensure that policy-makers, risk regulators, and 
stakeholder representatives engage in an open and transparent process of risk 
identification, communication and validation. This is important if policy choices are 
to reflect the public health concerns that they are designed to address. Such openness 
could also be beneficial in easing tensions around public acceptability of risk and 
build the much-needed trust relationships between all stakeholders in risk 
communication. The MHRA-led public consultation on whether to regulate ECs as 
medical devices, for example, enabled different groups within the public to express 
their views and input into the UK government decision to regulate EC as medical 
devices.  These public views were influential in allowing NHS doctors to prescribe 
ECs for smoking cessation purposes. Such risk communication practices could 
potentially eliminate inequalities in the representations of the risks that are often 
amplified through privileged stakeholder relationships and that therefore have a 
disproportionate influence on the policy approach taken to risk. Moreover, relying 
too much on technical expertise neglects other forms of (experiential) expertise, 
thereby reinforcing potential misconceptions about the threats to public health and 
safety.  This is particularly the case where the dominant view is around the need for 
proof of harm rather than proof of safety.  
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An alternative would be to take more a precautionary approach to dealing with the 
introduction of new forms of activity that may represent the potential for harm, 
although there are also challenges with such an approach (e.g. over regulation) 
(Calman & Smith, 2001; Fischbacher-Smith & Calman, 2010). In engaging the wider 
public, there is an opportunity to take advantage of recent advances in 
communication technologies (e.g. social media) to share views, information, 
expertise and opinion and, to an extent, redistribute power associated with control of 
communication (Riedlinger & Rea, 2015).  Any public debate would need to not 
only acknowledge different communication methods but also create formal space for 
views to be debated effectively and incorporated formally within decision-making 
processes. 
 
Secondly, academics have a responsibility to ensure the integrity of evidence that 
is relied upon for risk decisions. They must do more to interrogate new scientific 
evidence and challenge associated scientific assumptions that shape in particular, 
policy perspectives taken with regards to managing the risk. This was effectively 
illustrated in the e-cigarette debate where public health and medical experts 
challenged the arguments put forward by nicotine science specialists and public 
health policy experts, saying that they should resist the urge to regulate ECs in the 
same manner as tobacco products (Dreaper, 2014). Such practices could potentially 
reduce the abuse of science for personal/group gains at the detriment of public 
health. One might also argue that the credibility of scientific evidence and argument 
is also key to creating impact and enabling a sustainable environment in which 
balanced and robust science thrives, making it easier to discern science from political 
decisions. 
 
Academics must also do more to counter the enduring ideology that the experience 
and expertise of those in close proximity to the risk is anecdotal and therefore, bad 
science. Rather, they should adopt an approach where contrary experiences are 
valued and determine how facts and evidence relate with them (Brown, 2016). 
Furthermore, academics can do more to make scientific information more useable 
and accessible to different public audience to enable them participate fully in policy 
decisions that affect them.  
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Thirdly, the media has a duty to ensure that there is unambiguous and balanced, 
evidence-based journalism and to ensure that this reflects the diversity of public 
concerns, more explicitly bringing these to the consciousness of experts, academics 
and politicians, and highlighting uncertainties where they exist. This is important in 
the social media age where it may be difficult to discern the differences between 
credible arguments from propaganda when dealing with public health risk issues or 
emergencies. Parents and educators also have a role here in ensuring that relevant 
skills such as critical thinking needed to evaluate the credibility of risk information 
are developed as early as possible (Quick & Larson, 2018). 
 
Finally, care must be taken in how risk issues are codified in order to avoid 
communication barriers (Bernstein, 2003). Framing the risk agenda and asking clear 
risk questions with, and for, the public that are devoid of complexity has the 
potential to encourage public engagement in the policy decision processes. Again, 
this occurred in the case of the MHRA led public consultation with responses from 
different public groups (including medical profession and consumers of NCPs) who 
were able comment and express their views in the policy decision process.  
 
If we are to ensure that policy decisions relating to risk are not solely the product of 
powerful stakeholders who are able to shape the risk debate, there is a need to 
embrace what Irwin (2015) described as “contemporary knowledge relations” (p.10) 
where citizens as well as scientific and institutional organisations engage in critical 
reflection and reflection-informed practice. In this way, there is greater potential to 
break power barriers in public health policy-making. 
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